• ABOUT
    • Our Company
    • Our Team
    • Our Technology
  • SOLUTIONS
    • Pig Models
    • Preclinical
  • NEWSROOM
    • News
    • Publications
  • CONTACT
  • ABOUT
    • Our Company
    • Our Team
    • Our Technology
  • SOLUTIONS
    • Pig Models
    • Preclinical
  • NEWSROOM
    • News
    • Publications
  • CONTACT
  • ABOUT
    • Our Company
    • Our Team
    • Our Technology
  • SOLUTIONS
    • Pig Models
    • Preclinical
  • NEWSROOM
    • News
    • Publications
  • CONTACT
  • ABOUT
    • Our Company
    • Our Team
    • Our Technology
  • SOLUTIONS
    • Pig Models
    • Preclinical
  • NEWSROOM
    • News
    • Publications
  • CONTACT

Tag: medical research

If you didn’t find what you were looking for, try a new search!

Modernization of Healthcare Services to Propel Gene Editing Market

Read More

Novel Swine Model Developed for Neurofibromatosis Type 1

Read More

Recombinetics Announces Major Advancements in the Development of a Novel Swine Model of Neurofibromatosis Type 1

Read More

Regenerative Medicine Minnesota Biobusiness Award Winners Named

Read More

Gene Editing Market Outlook: Biotech & Pharma to be the Leading End-User

Read More

Failing Fast: Innovation in the Search for a Cure to Alzheimer’s

Read More

Recombinetics to Develop Alzheimer’s, Neurofibromatosis Swine Models for NIH

Read More

U Of M-Developed Gene Editing Technologies Making Waves In Agriculture, Medicine

Read More

NIH Awards Recombinetics a Research Grant to Develop Swine Model of Alzheimer’s

Read More

Using Precision-Genetics in Pigs to Beat Cancer

Read More
600 County Rd D West Ste 8, New Brighton, MN
55112
612-727-2000
info@recombinetics.com
  • © Copyright 2026 RECOMBINETICS
  • ALL RIGHTS RESERVED
  • Privacy Policy
  • © Copyright 2026 RECOMBINETICS
  • ALL RIGHTS RESERVED
  • Privacy Policy